Catalyst Wire Dossier Catalyst Wire Dossier

LICART

DICLOFENAC EPOLAMINE · IBSA Pharma Inc.
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for LICART, covering 2018-12-19 to 2026-03-27. Get the full timeline:

Most recent: FDA Approved: LICART — Supplemental Application (IBSA Pharma Inc.)

See pricing